Alterations in T cell phenotype and human immunodeficiency virus type 1-specific cytotoxicity after potent antiretroviral therapy.
about
Dendritic cells reveal a broad range of MHC class I epitopes for HIV-1 in persons with suppressed viral load on antiretroviral therapyModulation of human immunodeficiency virus (HIV)-specific immune response by using efavirenz, nelfinavir, and stavudine in a rescue therapy regimen for HIV-infected, drug-experienced patients.HIV-Specific CD8(+) T Lymphocytes in Blood of Long-Term HIV-Infected Hemophilia Patients.Low frequency of cytotoxic T lymphocytes against the novel HLA-A*0201-restricted JC virus epitope VP1(p36) in patients with proven or possible progressive multifocal leukoencephalopathy.Biphasic decay kinetics suggest progressive slowing in turnover of latently HIV-1 infected cells during antiretroviral therapy.The Impact of Sex Work Interruption on Blood-Derived T Cells in Sex Workers from Nairobi, Kenya.
P2860
Alterations in T cell phenotype and human immunodeficiency virus type 1-specific cytotoxicity after potent antiretroviral therapy.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Alterations in T cell phenotyp ...... potent antiretroviral therapy.
@ast
Alterations in T cell phenotyp ...... potent antiretroviral therapy.
@en
type
label
Alterations in T cell phenotyp ...... potent antiretroviral therapy.
@ast
Alterations in T cell phenotyp ...... potent antiretroviral therapy.
@en
prefLabel
Alterations in T cell phenotyp ...... potent antiretroviral therapy.
@ast
Alterations in T cell phenotyp ...... potent antiretroviral therapy.
@en
P2093
P356
P1476
Alterations in T cell phenotyp ...... potent antiretroviral therapy.
@en
P2093
Collier AC
McElrath MJ
Schmitz JE
P304
P356
10.1086/318816
P407
P577
2001-02-01T00:00:00Z